Silybin

The major active component of silymarin flavonoids extracted from seeds of the MILK THISTLE, Silybum marianum; it is used in the treatment of HEPATITIS; LIVER CIRRHOSIS; and CHEMICAL AND DRUG INDUCED LIVER INJURY, and has antineoplastic activity; silybins A and B are diastereomers.

Also Known As:

Lagosa; 2,3-Dehydrosilybin; Alepa-forte; Ardeyhepan; Cefasilymarin; Durasilymarin; Hepa-Merz Sil; Hepa-loges; HepaBesch; Hepar-Pasc; Heparsyx; Heplant; Legalon Forte; Silibin; Silibinin; Silibinin A; Silibinin B; Silybin A; Silybin B; Silybinin; 2,3 Dehydrosilybin; Alepa forte; Hepa Merz Sil; Hepa loges; Hepar Pasc; 4H-1-Benzopyran-4-one, 2- ((2R,3R)- 2,3- dihydro- 3- (4- hydroxy- 3- methoxyphenyl)- 2- (hydroxymethyl)- 1,4- benzodioxin- 6- yl)- 2,3- dihydro- 3,5,7- trihydroxy- , (2R,3R)-

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Pyrans: 131
    - Benzopyrans: 198
      - Chromones: 161
        Flavonoids: 10180
        Flavonolignans: 40
        Silymarin: 1204
        Silybin: 1025
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 198
      - Chromones: 161
        Flavonoids: 10180
        Flavonolignans: 40
        Silymarin: 1204
        Silybin: 1025

Hao-Yang Yu Selected Research

Hao-Yang Yu Research Topics

Disease

Drug/Important Bio-Agent (IBA)